{"id":"W1967101890","doi":"10.1002/art.33353","title":"Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources","keywords":"Medicine; Ocrelizumab; Rheumatoid arthritis; Placebo; Internal medicine; Rheumatology; Adverse effect; Arthritis; Methotrexate; Pathology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002984115,0.0006798249,0.003631247,0.0008354741,0.0003013624,0.00009864268,0.0002030047,0.0002185681,0.0001871773],"category_scores_gemma":[0.001476724,0.0005747494,0.0002662702,0.0004812574,0.0009488658,0.001003746,0.000237103,0.0004528686,0.00001286243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001351565,"about_ca_system_score_gemma":0.0001771864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001489186,"about_ca_topic_score_gemma":0.001724371,"domain_scores_codex":[0.9927404,0.001157554,0.002860104,0.0008235507,0.00125612,0.001162255],"domain_scores_gemma":[0.9950548,0.001831773,0.0009138686,0.0007482669,0.0003199748,0.001131353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8773118,0.003686867,0.0017136,0.00006918296,0.000410909,0.00002376914,0.006230821,0.00000455361,0.00054842,0.000321823,0.00007097832,0.1096073],"study_design_scores_gemma":[0.9658294,0.012791,0.01333546,0.006103686,0.00002328652,0.00009685288,0.0002954422,0.00006890932,0.0005452257,0.00006201997,0.0002915182,0.0005572303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714195,0.01731468,0.0001518474,0.0002879245,0.0001561059,0.009981181,0.0004874043,0.00006305299,0.000138331],"genre_scores_gemma":[0.9476851,0.04987271,0.001322696,0.00004214217,0.00004429859,0.000648555,0.0002318486,0.00009891156,0.00005369884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.10905,"threshold_uncertainty_score":0.9996704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0175188673964018,"score_gpt":0.2739853887195389,"score_spread":0.2564665213231371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}